2019 Webinars
Collapse Applications of Long-read Sequencing Technology for Cancer Transcriptomics and to Understand Influenza Infection (CE Available)

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

Recent advances in long-read sequencing technologies allows for a more complete identification of DNA and RNA associated with human disease. Two talks will be given to describe a few applications of these technologies.

The first talk will present nanopore sequencing of full-length cDNA from chronic lymphocytic leukemia (CLL) with and without mutation in a splicing factor, SF3B1. SF3B1 is one of the most frequently mutated genes in and is associated with poor patient prognosis. While alternative splicing patterns caused by mutations in SF3B1 using short-read sequencing are known, identifying the full-length isoform changes may better elucidate the functional consequences of these mutations. The talk will describe a computational workflow for transcript analysis called FLAIR (Full-Length Alternative Isoform analysis of RNA), novel findings, and remaining challenges with long-read sequencing approaches for alternative splicing analysis.

The second talk will present single-molecule real time sequencing of influenza. Infection by influenza virus can activate innate immune pathways that help control viral infection. However, these pathways are only rarely activated in single virus-infected cells. This webcast will describe how combining long-read sequencing with other single-cell techniques to determine how mutations in influenza virions affect whether infected cells activate innate immune pathways.
 


Speakers: Angela N. Brooks, PhD and Jesse D. Bloom, PhD

Moderator: Cecilia S. Yeung, MD

Duration: 1 hr

Level of Instruction: Basic


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM 1.0

Purchase Webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by March 20, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Brooks & Bloom Presentation
Original Course Date: August 06, 2019
MORE INFOMORE INFO Applications of Long-read Sequencing Technology for Cancer Transcriptomics and to Understand Influenza Infection (CE Available)
Collapse LIVE WEBINAR: PARP Inhibitors in the Clinic: The Implications of Genetic Testing for Treatment Selection and Germline Counseling

REGISTER FOR THIS LIVE WEBINAR!

Speaker: 

Katherine Nathanson, M.D.

Speaker: 

Payal Shah, M.D.

Moderator:

Tracy Stockley, Ph.D.

 


 

Description: In this webinar, Drs. Nathanson and Shah will describe the biological basis for pathogenicity of variants and the clinical interpretation of genetic testing results. Additionally the speakers will provide insight into the clinical significance of pathogenic variants with a focus on BRCA1 and BRCA2, including risk mitigation measures and therapeutic implications.


 

 Duration: 1 hr

Level of Instruction: Basic

AMA PRA Category 1 Credit(s) &trade

Physicians:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

CMLE Credit: The ASCP designates this activity for a maximum of 1.0 Continuing Medical Laboratory Education (CMLE) credit hour. CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

SAM Credit: This activity is approved by the American Board of Pathology for up to 1.00 SAM credit. Physicians should claim only credit commensurate with the extent of their participation in the activity. Learners must pass the post-test with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.  If you are seeking continuing education credit for an accrediting board other than the ABP, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. 


“Targeting DNA Repair Pathways: Current and Future Implications of PARP Inhibitors” is an up-to-date and useful three-part webcast series that will cover: 1. The mechanism of action of PARP inhibitors and the science of Homologous Recombination Deficiency (HRD) testing, 2. Laboratory considerations (from sample acquisition to result reporting) for HRD testing, and 3. Clinical considerations for testing and treatment and the need for genetic counseling.

This program has been supported through educational grants from AstraZeneca & Merck

Formats Available: Nathanson_Shah_Presentation
Original Course Date: October 22, 2019
On-Demand Release Date: Available Now
MORE INFOMORE INFO LIVE WEBINAR: PARP Inhibitors in the Clinic: The Implications of Genetic Testing for Treatment Selection and Germline Counseling
Collapse Making TMB Relevant in the Clinic: Best Practices for TMB Calculation, Reporting, and Interpretation (CE Available)

Speaker:

Albrecht Stenzinger, M.D.

Moderator:

Jonathan Nowak, M.D.,Ph.D.

 

This webinar is a recorded presentation of a live broadcast and includes the presentation, handout, and the audience QA. If you would like continuing education credit for the webinar, click on the links in the table below to access the webinar + CME/CMLE or webinar + SAM.


Description: Approaches to calculating, reporting, and interpreting Tumor Mutational Burden (TMB) testing will be discussed in this second of two updates on the broader use of TMB as a potentially prognostic and predictive tool in clinical care. Dr. Stenzinger will provide an overview of how large-scale efforts to harmonize TMB measurement may bolster the potential clinical utility of TMB reporting.

Duration: 1 hr

Level of Instruction: Basic

This webinar is part 2 of a two-part series exploring the role of TMB testing in relationship to other tumor biomarkers as well as the standardization of TMB testing.


This program has been supported through an educational grant from Bristol-Myers Squibb.


AMP is pleased to collaborate in the Immunotherapy Collaborative of Oncology Networked Communities, IC-ONC.  IC-ONC is a global information network in which multidisciplinary healthcare providers, responsible for treating patients with cancer, are connected via education.  

Please be sure to visit www.ic-onc.org to learn more about the collaborative and all it has to offer.


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Free for all)

SAM 1.0

Purchase Webinar + SAM

(Free for all)

Continuing Education Credit must be purchased and claimed by December 31, 2021

 

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

Formats Available: Stenzinger Presentation Only
Original Course Date: August 15, 2019
MORE INFOMORE INFO Making TMB Relevant in the Clinic: Best Practices for TMB Calculation, Reporting, and Interpretation (CE Available)
Collapse Recommendations for Clinical <i>CYP2C9</i> Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists (CE Available)

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

The goals of the Association for Molecular Pathology Pharmacogenomics (PGx) Working Group of the Association for Molecular Pathology Clinical Practice Committee are to define the key attributes of PGx alleles recommended for clinical testing and a minimum set of variants that should be included in clinical PGx genotyping assays. The CYP2C9 project and manuscript provides recommendations for a minimum panel of variant alleles (Tier 1) and an extended panel of variant alleles (Tier 2) that will aid clinical laboratories when designing assays for CYP2C9 testing.


Practice Guideline Available Here

Speaker: Stuart A. Scott, PhD, FACMG

Moderator: Yuan Ji, PhD, FACMG

Duration: 1 hr

Level of Instruction: Basic


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM 1.0

Purchase Webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by March 20, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

 

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Streaming
Original Course Date: September 05, 2019
MORE INFOMORE INFO Recommendations for Clinical <i>CYP2C9</i> Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists (CE Available)
Collapse Updates on Tumor Mutational Burden and the Immunotherapy Biomarker Landscape (CE Available)

Speaker:

Laura Tafe, M.D.

Moderator:

Jonathan Nowak, M.D.,Ph.D.

 

This webinar is a recorded presentation of a live broadcast and includes the presentation, handout, and the audience QA. If you would like continuing education credit for the webinar, click on the links in the table below to access the webinar + CME/CMLE or webinar + SAM. 


Description: This webinar will act as an overview and update regarding the use of Tumor Mutational Burden (TMB) as a diagnostic and prognostic tool. Advances in massively parallel sequencing technologies has facilitated the large scale examination of the mutational profile of tumors. Best practices with regard to elaboration of these techniques is evolving as is the correlation of results with clinical outcomes. This presentation will provide additional information regarding the newest innovations as well as implications for TMB testing, interpretation, and reporting. Some clinical applications and challenges will be discussed.

Duration: 1 hr

Level of Instruction: Basic

This webinar is part 1 of a two-part series exploring the role of TMB testing in relationship to other tumor biomarkers as well as the standardization of TMB testing.


This program has been supported through an educational grant from Bristol-Myers Squibb.


AMP is pleased to collaborate in the Immunotherapy Collaborative of Oncology Networked Communities, IC-ONC.  IC-ONC is a global information network in which multidisciplinary healthcare providers, responsible for treating patients with cancer, are connected via education.  

Please be sure to visit www.ic-onc.org to learn more about the collaborative and all it has to offer.


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Free for all)

SAM 1.0

Purchase Webinar + SAM

(Free for all)

Continuing Education Credit must be purchased and claimed by December 31, 2021

 

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

Formats Available: Tafe Presentation
Original Course Date: June 06, 2019
MORE INFOMORE INFO Updates on Tumor Mutational Burden and the Immunotherapy Biomarker Landscape (CE Available)
Collapse Using Machine Learning to Improve Variant Reporting (CE Available)

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

Next-generation sequencing technologies are actively applied in clinical oncology. Bioinformatics pipeline analysis is an integral part of this process; however, humans cannot yet realize the full potential of the highly complex output and the decision to include a variant in the final report remains challenging.  Machine learning is one approach to mine big data and derive models for decision-making.  Given that bioinformatics pipelines generate mostly structured, discrete data, the setting is ideal to assess a machine learning decision support system.  A decision support tool for variant reporting is a relevant approach to harness the next-generation sequencing bioinformatics pipeline output when the complexity of data interpretation exceeds human capabilities.  How can this be accomplished?  What are other use cases? What are the concrete steps for implementation?  In this upcoming webcast, Dr. Joe Lennerz from the Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School will address these questions.   


Speaker: Jochen K. Lennerz, MD, PhD

Moderator: Sabah Kadri, PhD

Duration: 1 hr

Level of Instruction: Intermediate


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM 1.0

Purchase Webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by March 20, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Lennerz Presentation
Original Course Date: September 10, 2019
MORE INFOMORE INFO Using Machine Learning to Improve Variant Reporting (CE Available)